TITLE

Choice among penicillins and cephalosporins

AUTHOR(S)
Garrod, L P
PUB. DATE
July 1974
SOURCE
British Medical Journal;7/13/1974, Vol. 3 Issue 5923, p96
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64111049

 

Related Articles

  • Manner of Action of the Penicillins and Cephalosporins. Jones, R. G. // Clinical Pediatrics;Mar1971, Vol. 10 Issue 3, p147 

    Describes the mechanism of action of penicillin and cephalosporins.

  • Diagnosis and Management of Penicillin Allergy. Park, Miguel A.; Li, James T. C. // Mayo Clinic Proceedings;Mar2005, Vol. 80 Issue 3, p405 

    Among patients with a reported history of penicillin allergy, 80% to 90% have no evidence of IgE antibodies to penicillin on skin testing and thus avoid penicillin unnecessarily. Moreover, 97% to 99% of such patients with a penicillin skin test negative to the major and minor determinants can...

  • Resistance to Penicillin and Cephalosporin and Mortality from Severe Pneumococcal Pneumonia in Barcelona, Spain. Pallares, Roman; Liñares, Josefina; Vadillo, Miquel; Cabellos, Carmen; Manresa, Frederic; Viladrich, Pedro F.; Martin, Rogelio; Gudiol, Francesc // New England Journal of Medicine;8/24/95, Vol. 333 Issue 8, p474 

    Background: Penicillin-resistant strains of Streptococcus pneumoniae are now found worldwide, and strains with resistance to cephalosporin are being reported. The appropriate antibiotic therapy for pneumococcal pneumonia due to resistant strains remains controversial. Methods: To examine the...

  • Cephalosporins often safe in penicillin allergy.  // Pulse;5/18/2011, Vol. 71 Issue 18, p11 

    The article reports on the use of cephalosporins as alternative treatment for patients who are allergic to penicillin.

  • Selecting the Optimal Antibiotic in the Treatment of Group A β-Hemolytic Streptococci Pharyngitis. Casey, Janet R. // Clinical Pediatrics;May2007 Supplement, Vol. 46 Issue S4, p25S 

    Treatment guidelines from the Infectious Diseases Society of America, the American Heart Association, and the American Academy of Pediatrics recommend only oral penicillin V or intramuscular benzathine penicillin G as the treatments of choice for group A β-hemolytic streptococcal pharyngitis....

  • The risk of cross-sensitive drug reactions. Porterfield, Linda M.; Hurley, Mary Lou // RN;Oct95, Vol. 58 Issue 10, p72 

    Reports that patients allergic to penicillin may also be allergic to cephalosporin, which is similar to penicillin. Use of erythromycin as an alternate antibiotic.

  • Testing for penicillin susceptibility needed in treating streptococcal endocarditis.  // Cortlandt Forum;02/25/99, Vol. 12 Issue 2, p21 

    Recommends the testing for penicillin susceptibility in treating streptococcal endocarditis. Increasing resistance of viridans streptococci to penicillin and cephalosporin.

  • Cephalosporin Allergy in Patients with Penicillin Allergy.  // Annals of Internal Medicine;7/6/2004, Vol. 141 Issue 1, p48 

    The article throws light on the cephalosporin allergy patients with pencillin allergy. Allergic reactions to penicillin antibiotics are common. Cephalosporins are other antibiotics that fight many of the same infections as penicillin. Some patients who are allergic to penicillin are also...

  • IgE-Mediated Hypersensitivity to Cephalosporins. Guéant, Jean-Louis; Guéant-Rodriguez, Rosa-Maria; Viola, Marinella; Luigi Valluzzi, Rocco; Romano, Antonino // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 26, p3335 

    Like penicillins, cephalosporins may cause IgE-mediated reactions such as urticaria, angioedema, and anaphylactic shock, which occur because of sensitization to determinants shared with penicillins or to unique cephalosporin haptens. In particular, side-chain structures may be responsible for...

  • The Role of Vancomycin in the Treatment Paradigm. Stevens, Dennis L. // Clinical Infectious Diseases;1/2/2006, Vol. 42, pS51 

    Vancomycin was introduced in the United States in 1956 as a possible treatment for infections due to penicillin-resistant Staphylococcus aureus, but it was not used widely because of toxicity and the nearly simultaneous development of semisynthetic antibiotics and cephalosporins. Thus, its main...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics